Unique classification of parathyroid dysfunction in patients with transfusion dependent thalassemia major using Nomogram-A cross sectional study

被引:4
作者
Majid, Hafsa [1 ]
Jafri, Lena [1 ]
Ahmed, Sibtain [1 ]
Talati, Jamsheer [2 ]
Moiz, Bushra [3 ]
Khan, Aysha Habib [1 ]
机构
[1] Aga Khan Univ, Dept Pathol & Lab Med, Sect Clin Chem, Stadium Rd,POB 3500, Karachi 74800, Pakistan
[2] Aga Khan Univ, Dept Surg, Stadium Rd,POB 3500, Karachi 74800, Pakistan
[3] Aga Khan Univ, Dept Pathol & Lab Med, Sect Hematol, Stadium Rd,POB 3500, Karachi 74800, Pakistan
关键词
beta thalassemia major (beta-TM); Parathyroid hormone (PTH); Intact parathyroid hormone (iPTH); Primary hypoparathyroidism; Sub-clinical hypoparathyroidism; Vitamin D deficiency (VDD); Secondary hyperparathyroidism (SHPT); HYPOPARATHYROIDISM; STATEMENT; HYPERPARATHYROIDISM; MANAGEMENT;
D O I
10.1016/j.amsu.2019.07.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Hypoparathyroidism is a rare complication of iron overload in patients with transfusion dependent beta thalassemia major (beta-TM). We aim to determine the prevalence of parathyroid dysfunction in patients with beta-TM. Methods: Diagnosed cases of transfusion dependent beta-TM between 5 and 17 years of age were recruited from outpatient clinics of a non-profit organization in Karachi, Pakistan. Blood and urine samples were collected in fasting to determine Ca, P, Alb, Mg, Cr 25OHD and iPTH. Patients were grouped on the basis of upper and lower levels of Ca, 25OHD and iPTH for assessing parathyroid dysfunction into primary hypoparathyroidism [low calcium (Ca) & intact parathyroid hormone (iPTH)], sub-clinical hypoparathyroidism [low iPTH and 25 hydroxy vitamin D (25OHD), low/normal Ca], normal functioning parathyroid gland [Normal Ca, iPTH and 25OHD] and secondary hyperparathyroidism [high iPTH, low/normal Ca and/or 25OHD]. Using PTH nomogram subject specific expected PTH (maxPTH) was calculated. Difference between maxPTH and measured iPTH was determined to assess the utility of nomogram in identifying parathyroid gland dysfunction. The statistical analysis was performed using the Statistical Package of Social Sciences (SPSS) version 20. Results: Median age of patients was 11 years (13-7) with males being 54.2% (n= 205). Based on Ca, 25OHD and iPTH, primary hypoparathyroidism was identified in 3.4% (n= 13) [median iPTH 11.3 pg/ml (12.6-7)], 52.3% (n= 192) had subclinical hypoparathyroidism [iPTH 40.4 pg/ml (52.7-28.7)], and 34% (n= 125) were identified as secondary hyperparathyroidism [iPTH 88.6 pg/ml (116-74.7)]. Normal response to Ca & 25OHD was seen in 10.6% (n= 39) [iPTH 44.2 pg/ml (53.8-33.4)] patients. High phosphorous was present in all groups. Difference between maxPTH & iPTH was highest in primary hypoparathyroidism, followed by subclinical and secondary hyperparathyroidism. Conclusion: Nomogram by Harvey et al. identify low secretion capacity of parathyroid gland that correlated with biochemical classification of patients. It requires clinical validation before using in clinical practice for assessing parathyroid dysfunction.
引用
收藏
页码:22 / 26
页数:5
相关论文
共 15 条
[1]   The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery [J].
Agha, Riaz Ahmed ;
Borrelli, Mimi R. ;
Vella-Baldacchino, Martinique ;
Thavayogan, Rachel ;
Orgill, Dennis P. .
INTERNATIONAL JOURNAL OF SURGERY, 2017, 46 :198-202
[2]   Hypothyroidism and Hypoparathyroidism in Thalassemia Major Patients: A Study in Sistan and Baluchestan Province, Iran [J].
Bazi, Ali ;
Harati, Hadi ;
Khosravi-Bonjar, Ali ;
Rakhshani, Elham ;
Delaramnasab, Mojtaba .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 16 (02)
[3]   Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop [J].
Bilezikian, John P. ;
Khan, Aliya A. ;
Potts, John T., Jr. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) :335-339
[4]   Management of Hypoparathyroidism: Summary Statement and Guidelines [J].
Brandi, Maria Luisa ;
Bilezikian, John P. ;
Shoback, Dolores ;
Bouillon, Roger ;
Clarke, Bart L. ;
Thakker, Rajesh V. ;
Khan, Aliya A. ;
Potts, John T., Jr. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (06) :2273-2283
[5]   Normocalcemic Hyperparathyroidism and Hypoparathyroidism in Two Community-Based Nonreferral Populations [J].
Cusano, Natalie E. ;
Maalouf, Naim M. ;
Wang, Patty Y. ;
Zhang, Chiyuan ;
Cremers, Serge C. ;
Haney, Elizabeth M. ;
Bauer, Douglas C. ;
Orwoll, Eric S. ;
Bilezikian, John P. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (07) :2734-2741
[6]  
De Sanctis V, 2006, J PEDIATR ENDOCR MET, V19, P471
[7]  
De Sanctis Vincenzo, 2018, Acta Biomed, V88, P435, DOI 10.23750/abm.v88i4.6837
[8]  
Di Maio Salvatore, 2018, Acta Biomed, V89, P122, DOI 10.23750/abm.v89i1.7118
[9]   Parathyroid and calcium status in patients with thalassemia [J].
Goyal M. ;
Abrol P. ;
Lal H. .
Indian Journal of Clinical Biochemistry, 2010, 25 (4) :385-387
[10]   A NEW, VITAMIN D-BASED, MULTIDIMENSIONAL NOMOGRAM FOR THE DIAGNOSIS OF PRIMARY HYPERPARATHYROIDISM [J].
Harvey, Adrian ;
Hu, MengJun ;
Gupta, Manjula ;
Butler, Robert ;
Mitchell, Jamie ;
Berber, Eren ;
Siperstein, Allan ;
Milas, Mira .
ENDOCRINE PRACTICE, 2012, 18 (02) :124-131